CA2427470A1 - Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function - Google Patents
Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function Download PDFInfo
- Publication number
- CA2427470A1 CA2427470A1 CA002427470A CA2427470A CA2427470A1 CA 2427470 A1 CA2427470 A1 CA 2427470A1 CA 002427470 A CA002427470 A CA 002427470A CA 2427470 A CA2427470 A CA 2427470A CA 2427470 A1 CA2427470 A1 CA 2427470A1
- Authority
- CA
- Canada
- Prior art keywords
- vitamin
- cognitive function
- day
- deterioration
- carnitine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24451100P | 2000-10-31 | 2000-10-31 | |
US60/244,511 | 2000-10-31 | ||
US25344600P | 2000-11-28 | 2000-11-28 | |
US25344700P | 2000-11-28 | 2000-11-28 | |
US60/253,446 | 2000-11-28 | ||
US60/253,447 | 2000-11-28 | ||
US09/922,633 US20020052402A1 (en) | 2000-10-31 | 2001-08-06 | Composition and method |
US09/922,633 | 2001-08-06 | ||
PCT/US2001/048665 WO2002043666A2 (en) | 2000-10-31 | 2001-10-30 | Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2427470A1 true CA2427470A1 (en) | 2002-06-06 |
Family
ID=27500158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002427470A Abandoned CA2427470A1 (en) | 2000-10-31 | 2001-10-30 | Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1339404A2 (zh) |
JP (1) | JP2004514686A (zh) |
CN (1) | CN1477958A (zh) |
AU (1) | AU2002232616A1 (zh) |
CA (1) | CA2427470A1 (zh) |
WO (1) | WO2002043666A2 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005185188A (ja) * | 2003-12-25 | 2005-07-14 | Nichirei Corp | アセロラ処理物およびl−カルニチン含有組成物 |
KR20060132667A (ko) * | 2004-01-28 | 2006-12-21 | 네스텍소시에테아노님 | 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물 |
EP1817058B1 (en) * | 2004-11-24 | 2015-09-02 | Hill's Pet Nutrition, Inc. | Composition for use in improving liver clearance of xenobiotic substances in an animal |
RU2394561C2 (ru) * | 2004-11-24 | 2010-07-20 | Хилл`С Пет Ньютришн, Инк. | Способы увеличения иммунного ответа у животного |
US20090176864A1 (en) * | 2004-11-24 | 2009-07-09 | Hill's Pet Nutrition, Inc. | Methods For Improving Hepatic and Immune Function In An Animal |
AU2006279429B2 (en) * | 2005-08-17 | 2010-02-25 | Hill's Pet Nutrition, Inc. | Methods and compositions for the prevention and treatment of kidney disease |
CN1895671B (zh) * | 2005-12-08 | 2012-11-28 | 淮北辉克药业有限公司 | 治疗病毒型肝病的复方制剂 |
CN101045048B (zh) * | 2006-03-27 | 2011-05-18 | 中国科学院上海生命科学研究院 | 线粒体营养素组合物的应用 |
US20100076091A1 (en) * | 2007-02-14 | 2010-03-25 | Tohoku University | Composition and method for suppressing lipooxidation of erythrocyte |
EP2923582B1 (en) * | 2009-07-14 | 2018-03-21 | Hill's Pet Nutrition, Inc. | Pet food compositions including sustained-release lipoic acid |
EP2508179A1 (en) | 2011-04-05 | 2012-10-10 | Lonza Ltd. | Use of L-Carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function |
CN103491954A (zh) | 2011-04-05 | 2014-01-01 | 隆萨有限公司 | L-肉碱、其盐及衍生物用于降低或预防疲劳和改善认知功能的用途 |
NL2024431B1 (en) * | 2019-12-11 | 2021-09-07 | Sulfateq Bv | Compounds for treatment of alzheimer’s disease |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06199690A (ja) * | 1992-03-06 | 1994-07-19 | Yunie:Kk | 脳代謝促進・脳機能改善剤 |
DE4343592C2 (de) * | 1993-12-21 | 1998-04-16 | Asta Medica Ag | Verwendung von R-(+)-alpha-Liponsäure und dessen Metaboliten in Form der freien Säure oder als Salze oder Ester oder Amide zur Behandlung von Glukosestoffwechselstörungen des zentralen Nervensystems |
FR2721516B1 (fr) * | 1994-06-27 | 1996-09-13 | Inst Rech Biolog Sa | Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation. |
US5977162A (en) * | 1996-09-16 | 1999-11-02 | Seidman; Michael D. | Therapeutic treatment for auditory function |
IT1302307B1 (it) * | 1998-09-01 | 2000-09-05 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil |
AU3287200A (en) * | 1999-03-16 | 2000-10-04 | Merck Patent Gmbh | Composition comprising isoquercetin and ascorbic acid in a sustained release form |
AU3913800A (en) * | 1999-03-26 | 2000-10-16 | Lipogenics, Inc. | Novel antioxidant formulations and methods for using them |
DE19920316A1 (de) * | 1999-05-03 | 1999-12-09 | Heinz Kiefer | Arzneimittel als Antioxidans mit einer Vitamin-Spurenelement-Kombination zur Förderung der Funktionstüchtigkeit der Zellen |
US6646013B1 (en) * | 1999-06-15 | 2003-11-11 | Nutri-Logics | Nutrient formulations for disease reduction |
WO2001032168A1 (en) * | 1999-11-03 | 2001-05-10 | Juvenon, Inc. | Method of treating benign forgetfulness |
CA2399319A1 (en) * | 2000-01-25 | 2001-08-16 | Nathan D. Hamilton | Nutritional supplements for aged pets |
HU227182B1 (en) * | 2000-03-06 | 2010-09-28 | Andras Javor | Lecitin-ascorbic acid combination |
-
2001
- 2001-10-30 AU AU2002232616A patent/AU2002232616A1/en not_active Abandoned
- 2001-10-30 CN CNA018181880A patent/CN1477958A/zh active Pending
- 2001-10-30 JP JP2002545645A patent/JP2004514686A/ja active Pending
- 2001-10-30 WO PCT/US2001/048665 patent/WO2002043666A2/en not_active Application Discontinuation
- 2001-10-30 CA CA002427470A patent/CA2427470A1/en not_active Abandoned
- 2001-10-30 EP EP01992146A patent/EP1339404A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002043666A2 (en) | 2002-06-06 |
CN1477958A (zh) | 2004-02-25 |
JP2004514686A (ja) | 2004-05-20 |
EP1339404A2 (en) | 2003-09-03 |
WO2002043666A3 (en) | 2003-01-30 |
AU2002232616A1 (en) | 2002-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8110600B2 (en) | Formulation and delivery method to enhance antioxidant potency of vitamin E | |
US6203818B1 (en) | Nutritional supplement for cardiovascular health | |
US6121249A (en) | Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins | |
US20020076470A1 (en) | Composition and method | |
CA2427470A1 (en) | Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function | |
US20020172721A1 (en) | Vitamin formulation for cardiovascular health | |
US20130045193A1 (en) | Compositions and methods for the prevention of cardiovascular disease | |
US20050239721A1 (en) | Methods for the treatment of peripheral neural and vascular ailments | |
BRPI0620210A2 (pt) | composição e processos para a inibição da progressão da degeneração macular e para promover visão saudável | |
RU2179440C2 (ru) | Композиция и способы подавления роста опухолевых клеток и опухоли с ее использованием | |
ES2546055T3 (es) | Complementos nutricionales para individuos de 50 años o más para mejorar la vitalidad, la inmunidad, la salud ocular y ósea | |
JP2008214338A (ja) | 高次脳機能低下改善剤および遅延記憶低下改善剤 | |
US20020076469A1 (en) | Composition and method | |
US20020052402A1 (en) | Composition and method | |
US20080241119A1 (en) | Micronutrient formulations for pulmonary and heart health | |
RU2484824C2 (ru) | Мультивитаминная/минеральная композиция для борьбы с эффектами экологического стресса, повышения иммунитета и повышения активности, направленная на недостаточности витаминов и минералов без негативных побочных эффектов мегадозовой пищевой добавки | |
US7399755B2 (en) | Formulations comprising multiple dietary and endogenously made antioxidants and B-vitamins and use of same | |
Subasree | Role of vitamin C and vitamin E in health and disease | |
ZA200303749B (en) | Compositions containing an antioxidant such as alpha lipoic acid, carnitine, Vitamin C or Vitamin E for preventing or inhibiting loss of cognitive function. | |
US6358997B1 (en) | Tocopherol and tocotrienol compositions | |
JP2005170834A (ja) | 皮膚改善製剤 | |
US6207187B1 (en) | Compositions based on tocopherols | |
US20130196934A1 (en) | Composition for perinatal and neonatal stroke | |
WO1996019218A1 (en) | Tocopherol and tocotrienol compositions | |
JP2006232815A (ja) | 血中CoQ10量を増加させる医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |